Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
No clinical trials have been registered for familial hypodysfibrinogenemia.
4 publications have been identified in PubMed for familial hypodysfibrinogenemia. Research spans Case Report / Case Series (50%), Review / Meta-Analysis (25%), and Epidemiology / Natural History (25%).
Bor MV (2026). [PMID: 41664865](https://pubmed.ncbi.nlm.nih.gov/41664865/). *Blood Coagul Fibrinolysis*. [Review / Meta-Analysis]
Chen W (2025). [PMID: 40506718](https://pubmed.ncbi.nlm.nih.gov/40506718/). *Thromb J*. [Case Report / Case Series]
Mohsenian S (2025). [PMID: 40727949](https://pubmed.ncbi.nlm.nih.gov/40727949/). *Res Pract Thromb Haemost*. [Epidemiology / Natural History]
Monard A (2024). [PMID: 39473893](https://pubmed.ncbi.nlm.nih.gov/39473893/). *Front Cardiovasc Med*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 7:14 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
AI-curated news mentioning familial hypodysfibrinogenemia
Updated Feb 10, 2026
A novel missense variant in the gamma chain of fibrinogen has been identified, causing hypodysfibrinogenemia in an asymptomatic Danish family. This discovery adds to the understanding of genetic variations affecting fibrinogen function.